drugset / Trial / NCT02638519

HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease

NCT02638519

RandomizedParallel-groupOpen-labelBasic science

Summary

This study involves imaging participants' brains using MRI. The goal is to develop a high-resolution, high-sensitivity imaging tool, hyperpolarized xenon functional brain magnetic resonance imaging, which can provide more sensitive measurement of brain function, facilitating the development of drugs for more successful treatment of Alzheimer's disease.

Timeline

Start
2016-06-27
Primary completion
2022-04-19
Completion
2022-04-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyperpolarized 129 Xenon Diagnostic / imaging agent Inhaled

Indications